Skip to main content
Boston Scientific10-Q: Restructuring charge

Board approved 2026 Restructuring Plan with expected charges of $700M to $800M

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.

What happened

On July 21, 2026, the Board approved a global restructuring plan targeting approximately $500 million in gross annual pre-tax expense reductions.

Source

SEC EDGARNov 2, 2026

Quarterly report (Form 10-Q)

Boston Scientific 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

On July 21, 2026, our Board of Directors approved, and we committed to, a new global restructuring program (the 2026 Restructuring Plan). The 2026 Restructuring Plan is intended to support our efforts to drive sustained cost efficiencies and enable continued growth by ensuring that we are structured and resourced to support our strategic priorities. The 2026 Restructuring Plan is expected to result in total pre-tax charges of approximately $700 million to $800 million, of which approximately $600 million to $700 million is expected to result in future cash outlays, and reduce gross annual pre-tax expenses by approximately $500 million as program benefits are realized.

sec.gov/Archives/edgar/data/885725/000088572526000070/bsx-20260930.htmRead the full source

Other signals in this filing (8)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring charge

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 2, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$800M (total pre-tax charges expected from the 2026 Restructuring Plan)

Details

CIK
885725
Accession number
0000885725-26-000070
Timeframe
Multi year
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Vendor review likely
Signal category
Financial

Extraction

Confidence
High
Relevance
85%
Sentiment
Negative
Detected
Nov 3, 2026
signal_type
sec-10q
signal_subtype
restructuringCharge

Use this data

Get every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6721e51f-2fcc-4394-b7f2-64cedc337271 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "6721e51f-2fcc-4394-b7f2-64cedc337271",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuringCharge",
  "detected_at": "2026-11-03T07:11:44.696+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "On July 21, 2026, the Board approved a global restructuring plan targeting approximately $500 million in gross annual pre-tax expense reductions. Enterprise transformation and organizational design vendors may find opportunities supporting the cost restructuring and strategic growth reinvestment initiatives.",
    "metrics": {
      "timeframe": "multi_year",
      "dollar_context": "total pre-tax charges expected from the 2026 Restructuring Plan",
      "dollar_millions": 800
    },
    "quarter": "Q3",
    "summary": "Board approved 2026 Restructuring Plan with expected charges of $700M to $800M",
    "excerpts": "On July 21, 2026, our Board of Directors approved, and we committed to, a new global restructuring program (the 2026 Restructuring Plan). The 2026 Restructuring Plan is intended to support our efforts to drive sustained cost efficiencies and enable continued growth by ensuring that we are structured and resourced to support our strategic priorities. The 2026 Restructuring Plan is expected to result in total pre-tax charges of approximately $700 million to $800 million, of which approximately $600 million to $700 million is expected to result in future cash outlays, and reduce gross annual pre-tax expenses by approximately $500 million as program benefits are realized.",
    "relevance": 0.85,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000070/bsx-20260930.htm",
    "filing_date": "2026-11-02",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Vendor review likely",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.